Lab-Grown Bone: 3D-Printed Collagen Scaffolds and Bioreactors Point to Off-the-Shelf Substitutes

Engineered bone tissue has long promised a future in which patients needing reconstructive surgery could receive ready-made, living bone substitutes grown in the laboratory rather than harvested from their own bodies. A new study published in Advanced Science brings that future measurably closer by chaining together three technologies that are usually pursued in isolation: high-throughput 3D printing of collagen scaffolds, industrial-scale expansion of human stem cells, and long-term cultivation inside a perfusion bioreactor. The result is a complete production pipeline for large, tailored, mineralized bone constructs that developed for sixty days without a single drop of the expensive growth factors that most tissue engineering protocols depend upon.

The first stage of the pipeline tackles a stubborn manufacturing problem. Collagen is the most biologically relevant material for bone scaffolds because it supports cell infiltration, osseointegration, and minimal immune reaction, yet it is notoriously difficult to print directly. Its poor structural stability means that large or irregularly shaped scaffolds tend to collapse under their own weight during printing, forcing researchers to add bulky support structures that must later be discarded. The research team, working across institutions in Germany and Europe, sidestepped this limitation entirely with a hybrid strategy. They 3D-printed a rigid polylactic acid male mold of the desired geometry, cast it in platinum-cured silicone to produce reusable female molds, and then poured rat-tail type I collagen gel into each mold. After lyophilization and cross-linking with glutaraldehyde vapor, the scaffolds emerged with centimeter-scale dimensions, tailored shapes, and sufficient mechanical integrity to spring back to their original form within minutes of being compressed during cell seeding.

This mold-based approach is as much an exercise in sustainability as in engineering. Because the printed molds can be replicated and processed in bulk, the method eliminates the quick-setting photo-crosslinkers and sacrificial support materials that direct bioprinting demands, reducing both material waste and production time. The authors explicitly framed the workflow around the 3R principles of replacement, reduction, and refinement, extending them from animal experimentation into the fabrication process itself. Each silicone mold holds two milliliters of collagen mix, and the resulting scaffolds come in two sections: a broad top section of roughly 0.19 cubic centimeters and a slim bottom section of about 0.10 cubic centimeters, allowing the team to study how geometry influences cell behavior within a single construct.

Before any scaffold could be seeded, the researchers needed a reliable supply of human bone marrow-derived mesenchymal stromal cells, or hMSCs, the workhorses of bone tissue engineering. Conventional culture flasks yield too few cells for large constructs, so the team scaled up expansion in 250-milliliter spinner flasks fitted with rod impellers and CultiSpher-S microcarrier beads. Computational fluid dynamics simulations revealed a linear relationship between stir rate and fluid shear, and identified 90 revolutions per minute as the sweet spot, producing a maximum shear stress of about 7.7 dynes per square centimeter that matched previously optimized conditions in smaller flasks. After twelve days, a single spinner flask yielded an average of 19.28 million cells, compared with only 7.84 million from two conventional T175 flasks, a more than fourfold improvement per vessel. Critically, the cells retained their spindle-like morphology, expressed the stemness markers CD90 and Sox2 at levels comparable to conventionally cultured cells, and passed standard trilineage differentiation assays, confirming that the gentle agitation had not compromised their multipotency.

With cells and scaffolds in hand, the team inoculated each construct with 3.5 million hMSCs, achieving seeding efficiencies of 63.4 percent for pure collagen scaffolds and 73.4 percent for scaffolds embedded with chondroitin sulfate A, a sulfated glycosaminoglycan naturally found in cartilage and bone. CSA is the study’s biochemical masterstroke. Rather than supplementing the culture with exogenous growth factors such as TGF-beta, BMP, IGF, or FGF, which are costly, poorly penetrating in large constructs, and biased toward particular cell types, the researchers embedded CSA directly into the collagen matrix. There it binds and stabilizes growth factors that the cells themselves produce, triggering chondrogenic differentiation. Removing CSA from the medium after fifteen days then allowed the differentiation program to pivot toward osteogenesis, mimicking the sequential choreography of endochondral ossification, the process by which long bones form during development and fracture healing.

The seeded constructs were then encapsulated in agarose bedding inside a perfusion bioreactor, where medium flowed at 5.5 milliliters per minute through hollow channels running parallel to the scaffolds. The agarose serves a dual role: it mimics the connective tissue that envelops native bone and it shields the fragile constructs from excessive fluid shear that would otherwise tear them apart. Fiber-optic oxygen sensors tracked partial oxygen tension at multiple positions over the full sixty days. The medium reservoir held steady at 137.5 millimeters of mercury, and within the constructs themselves, oxygen levels ranged between 58 and 102 millimeters of mercury, an oxygenated niche favorable to osteogenic differentiation. Notably, oxygen tension tracked cell density rather than absolute cell number, and it rose at day thirty when cell counts dipped before falling again as proliferation resumed, demonstrating that the bioreactor maintained a dynamically responsive but consistently oxygenated environment.

The contrast with conventional static culture was stark. After sixty days, constructs grown in the bioreactor retained their original cylindrical dimensions and structural integrity, while statically cultured counterparts shrank dramatically, with pure collagen scaffolds condensing so severely that their bottom sections collapsed. Micro-computed tomography revealed homogeneous mineralization throughout the perfused constructs, with calculated densities reaching up to 175 milligrams per cubic centimeter in collagen scaffolds, whereas static cultures showed dispersed, lower-density mineral deposits. Alizarin red staining confirmed these findings, revealing calcium accumulation in both the inner core and periphery of CSA-containing perfused constructs, while pure collagen constructs showed mineralization only along a thin, compact outer shell surrounding a collapsed interior.

Gene expression analysis told the developmental story in molecular terms. In CSA-containing constructs under perfusion, chondrogenic markers Sox9 and Col2a rose at thirty days, followed by the hypertrophic chondrocyte marker Col10a, and finally the osteoblast markers Runx2, ALP, and Sp7, precisely the sequence expected of endochondral ossification. Pure collagen constructs, by contrast, showed early Sp7 expression with low chondrogenic markers, a pattern consistent with intramembranous ossification, the route that produces compact hard bone directly. The fact that a single population of hMSCs could be steered down either developmental pathway, simply by choosing the scaffold composition and the timing of CSA withdrawal, underscores how much control the platform offers. Osteogenic differentiation was initiated with dexamethasone at one-billionth molar concentration, a hundredfold lower than conventional protocols, further reducing reliance on potent biochemical additives.

The implications extend beyond the laboratory bench. Off-the-shelf bone substitutes could transform treatment for large bone defects from trauma, tumor resection, or spinal fusion, where autologous grafts are limited in supply and carry donor-site morbidity. By demonstrating that large, geometrically tailored, mineralized constructs can be produced sustainably, without growth factor supplementation and with preserved structural integrity over two months of culture, the study establishes a practical baseline for scaling. The authors suggest next steps that include tuning medium pH and oxygen tension, incorporating endothelial cells for vascularization, and validating cell type distribution at the protein level against native bone tissue. They also envision the fluid dynamics model evolving into a digital twin, allowing impeller and flask designs to be optimized computationally before any wet-lab validation. If those refinements succeed, the assembly line described here, from printed mold to perfused, mineralized bone, could become the template for a genuinely industrial approach to regenerative medicine.

Subject of Research: Sustainable biofabrication of tailored collagen-based bone substitutes using scaled stem cell expansion and perfusion bioreactor cultivation

Article Title: Sustainable Fabrication of Tailored Bone Substitutes: From High‐Throughput Scaffold Manufacturing, Scaled‐Up HMSC Expansion to Dynamic Cultivation in a Perfusion Bioreactor

Article References: Braun, F., Paříková, A., Rother, S., Kantor, M., Ilyas, S. M., Bernhardt, R., Yomi, P. N., Havlica, J., Appali, R., Kruppke, B., & Lee, P. S. (2026). Sustainable Fabrication of Tailored Bone Substitutes: From High‐Throughput Scaffold Manufacturing, Scaled‐Up HMSC Expansion to Dynamic Cultivation in a Perfusion Bioreactor. Advanced Science, 13(56), Article e23846. https://doi.org/10.1002/advs.202523846

Image Credits: AI Generated

DOI: 10.1002/advs.202523846

Keywords: bone tissue engineering, collagen scaffolds, 3D printing, hMSCs, perfusion bioreactor, chondroitin sulfate A, endochondral ossification, spinner flask, mineralization, growth factors, sustainable fabrication, regenerative medicine